Cyclosporine and lipid peroxidation.
Kasiske
B L
BL
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA. kasis001@maroon.tc.umn.edu
D001379:Azathioprine / Q000494:pharmacology / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology; D016572:Cyclosporine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D016030:Kidney Transplantation; D015227:Lipid Peroxidation / Q000187:drug effects*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D010084:Oxidation-Reduction; D012307:Risk Factors
D007166:Immunosuppressive Agents; D008077:Lipoproteins, LDL; D016572:Cyclosporine; D001379:Azathioprine